Lyell Immunopharma, Inc. SC 13G and SC 13G/A reports

Location
201 Haskins Way, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/7/2024, 04:22 PM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Nov 4, 2024
SC 13G Report SC 13G Oct 31, 2024
SC 13G/A Report ARCH VENTURE FUND IX, L.P. - LYELL IMMUNOPHARMA -- SCH 13G/A(#1) Feb 14, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 13, 2024
SC 13G Report Jan 29, 2024
SC 13G/A Report SC 13G/A Feb 13, 2023
SC 13G Report SCHEDULE 13G Feb 9, 2023
SC 13G Report SC 13G Feb 14, 2022
SC 13G Report SC 13G Feb 14, 2022
SC 13G Report ARCH VENTURE FUND IX, L.P. - LYELL IMMUNOPHARMA -- SCH 13G Feb 14, 2022
SC 13G Report SC 13G Feb 11, 2022
SC 13G Report SCHEDULE 13G Feb 10, 2022